Latest Period
Q1 2026
Security Snapshot
CITIUS ONCOLOGY, INC. - Common Shares, $0.0001 par value per share (CTOR) Institutional Ownership
CUSIP: 17331Y109
13F Institutional Holders and Ownership History from Q3 2024 to Q1 2026
Institutions Reporting
13
Shares (Excl. Options)
14,247,638
Price
$0.62
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Shares, $0.0001 par value per share
- Symbol
- CTOR on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 14,247,638
- Total 13F value
- $8,828,728
- Portfolio coverage rank
- 0%
- Share change
- +7,326,724
- Value change
- +$4,455,955
- Number of holders
- 13
- Shares outstanding
- 93,027,627
- SEC-reported price per share
- $0.90
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- CTOR - CITIUS ONCOLOGY, INC. - Common Shares, $0.0001 par value per share is tracked under CUSIP 17331Y109.
- 13 institutions reported positions in Q1 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 17 to 13 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $6,861,177 to $8,828,728.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 13 institutions filings for Q1 2026.
Security key
17331Y109
Latest holder period
Q1 2026
13F holders
13
13D/G owners
2
CIK / CUSIP context first
Open Q1 2026 holders
CTOR full holder history
CITIUS ONCOLOGY, INC. SEC filings
CITIUS ONCOLOGY, INC. company facts
CITIUS ONCOLOGY, INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 17331Y109:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
CTOR
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Citius Pharmaceuticals, Inc. | 71% | -8.8% | $59,444,654 | 66,049,615 | 0% | Citius Pharmaceuticals, Inc. | 15 May 2026 | |
| ARMISTICE CAPITAL, LLC | 10% | 0% | $6,044,946 | +$793,983 | 9,299,917 | +15% | Armistice Capital, LLC | 31 Mar 2026 |
As of 31 Mar 2026, 13 institutional investors reported holding 14,247,638 shares of CITIUS ONCOLOGY, INC. - Common Shares, $0.0001 par value per share (CTOR). This represents 15% of the company’s total 93,027,627 outstanding shares.
13F concentration
Top 19 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
15%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 9.9% | 9,188,855 | +65% | 0.19% | $5,696,171 |
| BANK OF AMERICA CORP /DE/ | 4.1% | 3,835,160 | +1792031% | 0% | $2,373,964 |
| VANGUARD CAPITAL MANAGEMENT LLC | 0.57% | 534,824 | 0% | 0% | $331,591 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.28% | 264,733 | +20% | 0% | $164,107 |
| VANGUARD FIDUCIARY TRUST CO | 0.13% | 121,910 | 0% | 0% | $75,584 |
| IFP Advisors, Inc | 0.12% | 107,424 | +23% | 0% | $66,592 |
| BlackRock, Inc. | 0.05% | 47,454 | +112% | 0% | $29,417 |
| NORTHERN TRUST CORP | 0.05% | 45,746 | 0% | 0% | $28,358 |
| STATE STREET CORP | 0.05% | 42,900 | 0% | 0% | $26,594 |
| UBS Group AG | 0.04% | 36,840 | +72% | 0% | $22,840 |
| Arkadios Wealth Advisors | 0.01% | 11,666 | 0% | 0% | $7,232 |
| OSAIC HOLDINGS, INC. | 0.01% | 10,125 | -11% | 0% | $6,277 |
| Caitong International Asset Management Co., Ltd | 0% | 1 | 0% | $1 | |
| TWO SIGMA INVESTMENTS, LP | 0% | 0 | -100% | $0 | |
| TWO SIGMA SECURITIES, LLC | 0% | 0 | -100% | $0 | |
| OMERS ADMINISTRATION Corp | 0% | 0 | -100% | $0 | |
| XTX Topco Ltd | 0% | 0 | -100% | $0 | |
| Farther Finance Advisors, LLC | 0% | 0 | -100% | $0 | |
| Versant Capital Management, Inc | 0% | 0 | -100% | $0 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
7
Latest
Q1 2026
Rows shown
1-7 of 7
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 14,247,638 | $8,828,728 | +$4,455,955 | $0.62 | 13 |
| 2025 Q4 | 6,861,177 | $6,861,177 | -$1,583,956 | $1.00 | 17 |
| 2025 Q3 | 8,357,159 | $16,966,429 | +$16,255,712 | $2.03 | 16 |
| 2025 Q2 | 227,492 | $989,589 | +$573,842 | $4.35 | 7 |
| 2025 Q1 | 105,008 | $97,657 | -$115,519 | $0.93 | 6 |
| 2024 Q4 | 200,884 | $230,191 | +$180,602 | $1.15 | 11 |
| 2024 Q3 | 41,238 | $57,016 | +$57,016 | $1.39 | 7 |